Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System - 19/08/11
Résumé |
The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS) has been designed to assess systematically the safety of vaccines and medications during pregnancy and is suited ideally to evaluate the gestational safety of seasonal and pandemic influenza vaccine and influenza antivirals. VAMPSS is coordinated by the American Academy of Allergy Asthma and Immunology and includes 2 complimentary data collection arms (prospective cohort and case-control surveillance) and a standing independent advisory committee. Both data collection arms obtain information directly from the mother, which facilitates accurate capture of exposures and potential confounders. The full range of perinatal outcomes, which includes specific birth defects, is assessed. Information that is obtained from VAMPSS should allow enhanced prevention and improved treatment of influenza during pregnancy by the identification of any exposures that might be associated with important risks and the provision of reassurance for exposures that are found to be relatively safe.
Le texte complet de cet article est disponible en PDF.Key words : influenza, oseltamivir, perinatal outcomes, pregnancy, zanamivir
Plan
Supported by the Biomedical and Advanced Research and Development Authority (BARDA) of the United Stated Department of Health and Human Services (HHS). |
|
Conflict of Interest: none. |
|
Publication of this article was supported by the Centers for Disease Control and Prevention and the Association of Maternal and Child Health Programs. |
Vol 204 - N° 6S
P. S64-S68 - juin 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?